An infant develops bright erythema in neck folds after recent antibiotic use. Which is the first-line treatment for a candida skin infection in intertriginous areas?

An infant develops bright erythema in neck folds after recent antibiotic use. Which is the first-line treatment for a candida skin infection in intertriginous areas?

• A. Topical nystatin cream applied several times daily
• B. 1% hydrocortisone cream to affected areas for 1 to 2 days
• C. Oral fluconazole 6 mg/kg on day 1, then 3 mg/kg/dose for 14 days
• D. Topical keratolytics and topical antibiotics for 7 to 10 days

Answer: (A)

Candida loves warm, moist skin folds, especially after antibiotic use that can disrupt normal skin flora. When this fungus infects intertriginous areas in an infant, the goal is to deliver an antifungal directly to the affected skin to stop the overgrowth and promote healing. The best first step is a topical antifungal agent because it targets the fungus locally, is effective, and is safe for babies. Topical nystatin cream fits this role well. It acts by binding fungal cell membranes and causing leakage of cell contents, which helps clear Candida infections at the site. It’s well tolerated in infants and can be applied multiple times daily to the affected folds until the area clears, with attention to keeping the skin clean and dry and avoiding occlusive dressings that trap moisture. Hydrocortisone cream is not ideal as a first line here because steroids can dampen the immune response and may worsen a fungal infection or delay clearance by suppressing the local inflammatory reaction needed to fight the organism. Oral fluconazole is a systemic option reserved for more extensive disease, failure of topical therapy, or in certain high-risk settings; it carries more systemic exposure and isn’t normally needed for localized intertriginous candidiasis in otherwise healthy infants. Using keratolytics and topical antibiotics won’t address the fungal pathogen and can irritate the skin or promote further imbalance in the skin microbiome. So, starting with a topical antifungal like nystatin, applied to the affected areas several times daily, is the appropriate first-line approach.

Candida loves warm, moist skin folds, especially after antibiotic use that can disrupt normal skin flora. When this fungus infects intertriginous areas in an infant, the goal is to deliver an antifungal directly to the affected skin to stop the overgrowth and promote healing. The best first step is a topical antifungal agent because it targets the fungus locally, is effective, and is safe for babies.

Topical nystatin cream fits this role well. It acts by binding fungal cell membranes and causing leakage of cell contents, which helps clear Candida infections at the site. It’s well tolerated in infants and can be applied multiple times daily to the affected folds until the area clears, with attention to keeping the skin clean and dry and avoiding occlusive dressings that trap moisture.

Hydrocortisone cream is not ideal as a first line here because steroids can dampen the immune response and may worsen a fungal infection or delay clearance by suppressing the local inflammatory reaction needed to fight the organism. Oral fluconazole is a systemic option reserved for more extensive disease, failure of topical therapy, or in certain high-risk settings; it carries more systemic exposure and isn’t normally needed for localized intertriginous candidiasis in otherwise healthy infants. Using keratolytics and topical antibiotics won’t address the fungal pathogen and can irritate the skin or promote further imbalance in the skin microbiome.

So, starting with a topical antifungal like nystatin, applied to the affected areas several times daily, is the appropriate first-line approach.